Showing results (521-530 of 661) with videos related to
Sort By:
Pageof 67
Nature Cancer|December 21, 2022
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myelomaAndrea Keppler-Hafkemeyer, Christine Greil, Paul R Wratil, et al.Nature Cancer|February 5, 2022
Trispecific antibodies enhance the therapeutic efficacy of tumor-directed T cells through T cell receptor co-stimulationLan Wu, Edward Seung, Ling Xu, et al.Nature Cancer|February 5, 2022
Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancerYong Li, Yi He, Junya Peng, et al.Nature Cancer|February 5, 2022
Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunityShelley E Ackerman, Cecelia I Pearson, Joshua D Gregorio, et al.Nature Cancer|February 5, 2022
Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitorsJana Jeschke, Evelyne Collignon, Clémence Al Wardi, et al.Nature Cancer|February 5, 2022
Personalized circulating tumor DNA analysis as a predictive biomarker in solid tumor patients treated with pembrolizumabScott V Bratman, S Y Cindy Yang, Marco A J Iafolla, et al.Nature Cancer|February 5, 2022
Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitorsRom Keshet, Joo Sang Lee, Lital Adler, et al.Nature Cancer|February 5, 2022
Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effectsTomo Osako, Hakwoo Lee, Gulisa Turashvili, et al.Nature Cancer|February 5, 2022
Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasisMinhong Shen, Yong Wei, Hahn Kim, et al.Pageof 67